Freestyle Libre


You Can Do It WITHOUT Finger Sticks

The FreeStyle Libre 14 day system is an accurate, convenient, and easy way to get glucose readings and trends.


Two Components

innovative sensor technology

  • No fingerstick calibration required
  • Small, discreet, and water resistant*
  • Can be worn for up to 14 days
  • Sensor automatically measures glucose readings day and night

compact, lightweight reader

  • Painless, one-second scan - even through clothing
  • Stores up to 90 days of glucose data
  • Backlit touchscreen for visibility

How to get started with FreeStyle Libre 14 day system

1. Get a prescription

Request a written prescription. Your healthcare professional can use our example as a guide.


2. Contact GNS Med Supplies

Fill your prescriptions GNS Medical Supplies.

Please call 810-208-6006 or fax your prescription to 810-208-6007


Contact GNS Medical Supplies to order your FreeStyle Libre 14 day system

Call 810-208-6006 or Fax 810-208-6007

  1. GNS will handle all paperwork and qualifying
  2. Easy Ordering
  3. You will receive your new FreeStyle Libre 14 day system within 5 days
  4. Complete Monthly Refills with Ease
  5. Hardship Assistance for those who qualify


If you are covered by Medicare:

The FreeStyle Libre 14 day system is covered by Medicare for those who qualify.*

Medicare Coverage Criteria*

Check the criteria for coverage:
Therapeutic CGMs and related supplies are covered by Medicare when all the following coverage criteria are met:

  • The beneficiary has diabetes mellitus; and
  • The beneficiary has been using a blood glucose monitor (BGM) and performing frequent (4 or more times a day) testing; and
  • The beneficiary is insulin-treated with multiple (3 or more) daily injections of insulin or a Medicare covered continuous subcutaneous insulin infusion (CSII) pump; and
  • The beneficiary’s insulin treatment regimen requires frequent adjustment by the beneficiary on the basis of BGM or CGM testing results; and
  • Within six (6) months prior to ordering the CGM, the treating practitioner has an in-person visit with the beneficiary to evaluate their diabetes control and determined that criteria (1-4) above are met; and
  • Every six (6) months following the initial prescription of the CGM, the treating practitioner has an in-person visit with the beneficiary to assess adherence to their CGM regimen and diabetes treatment plan.